Zscaler (ZS) Stock Drops Despite Market Gains: Important Facts to Note

Zscaler shares closed at $196.60, down 1.1% on the day despite an 11.8% gain over the past month, outperforming both the technology sector's 6.36% rise and the S&P 500's 0.55% gain. Consensus expects upcoming quarterly EPS of $1.16, up 20.83% year over year, on revenue of $937.61 million, up 18.97%; full-year forecasts call for $4.91 EPS and $3.93 billion in revenue. The 30-day consensus EPS estimate has increased 451.17%, although Zscaler retains a Zacks Rank #3 (Hold).

Analysis

This is not a fundamental information event; the useful signal is that ZS has outperformed into earnings while the reported estimate revision is unusually large and likely contaminated by a prior-period consensus or accounting-base change. The key question is not whether ZS clears headline EPS, but whether billings/RPO, net retention, and large-enterprise deal duration support durable high-teens growth. A modest beat without forward billings acceleration would leave the stock exposed to post-print multiple compression after a strong one-month move.

Competitive read-through matters more than the single-session decline. ZS needs sustained platform consolidation wins to defend premium growth versus PANW, CRWD and FTNT; slower new-logo activity or greater discounting would suggest security budgets are being captured by broader vendors and endpoint consolidation. Conversely, evidence that zero-trust and data-protection modules attach at higher rates would improve mix and operating leverage, creating a 6-18 month catalyst beyond the near-term earnings setup.

Contrarian view: the apparent forward valuation discount versus the broad security cohort is not automatically cheapness; it can reflect uncertainty around growth durability and cash-billings conversion. The stock is actionable only if management demonstrates that growth is being driven by demand rather than easier comparisons, sales-force timing, or pricing concessions. Watch guidance for next-quarter revenue/billings, RPO growth, and calculated billings versus revenue; a material guide-up is needed to validate upside after the recent run.

Key Decisions for Investors

• No directional pre-earnings position based on this article alone. Set an alert for the earnings release: initiate a 1-3 month long ZS only on guidance implying reacceleration in billings/RPO and stable or improving operating margin; invalidate if forward growth guidance remains high-teens or lower without a corresponding margin step-up.
• Use a relative-value framework rather than outright beta: long ZS / short HACK or CIBR for 1-3 months only if ZS shows stronger large-deal and module-attach metrics than the group. Size small until billings and RPO data confirm the thesis; sector multiple expansion can overwhelm company-specific execution.
• If ZS beats EPS but forward billings/RPO disappoint, consider a tactical short or put spread after the initial reaction, targeting a reversal of part of the recent momentum move over days to weeks. Cover on a guide-up, evidence of accelerating data-protection adoption, or a broad cybersecurity risk-on rerating.
• Monitor PANW and CRWD commentary for pricing and platform-consolidation signals. A clear shift toward bundled platforms or lower renewal pricing would be a negative second-order read-through for ZS's standalone growth premium and argues against adding exposure.